Announcements Trials

Browse Landscape

Phase

Phase 1/2 3 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 45 Carcinoma, Renal Cell 19 Neoplasm Metastasis 16 Leukemia, Myeloid, Acute 15 Kidney Neoplasms 14 Skin Neoplasms 11 Neoplasms 10 Leukemia 7 Breast Neoplasms 7 Lymphoma, Non-Hodgkin 6 Myelodysplastic Syndromes 5 Ovarian Neoplasms 4 Neuroblastoma 4 Congenital Abnormalities 4 Colorectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Hodgkin Disease 3 Uveal Melanoma 2 Prostatic Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Myeloid 1 Sarcoma, Ewing 1 Sarcoma 1

Interventions

Cisplatin 88 Fluorouracil 71 Paclitaxel 69 Radiotherapy 63 Oxaliplatin 55 Irinotecan 37 Docetaxel 36 Carboplatin 36 Leucovorin 34 Capecitabine 28 Radiation 25 Surgical Procedures, Operative 22 Drug Therapy 19 pembrolizumab 18 Cetuximab 15 Bevacizumab 15 Nivolumab 14 tislelizumab 12 camrelizumab 11 Neoadjuvant Therapy 11 Esophagectomy 11 Chemoradiotherapy 11 S 1 (combination) 10 Albumin-Bound Paclitaxel 10 nimotuzumab 9 Trastuzumab 9 durvalumab 8 Radiotherapy, Intensity-Modulated 8 Gefitinib 7 Epirubicin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × Interleukin-2 × Clear all

NCT01795976 2018-08-07

ATTACK-OG

The Christie NHS Foundation Trust

Phase 2 Terminated

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡